Kai-Bo Wang | Anticancer Drug and Dairy Science | Innovative Research Award

Innovative Research Award

Kai-Bo Wang
China Pharmaceutical University
Kai-Bo Wang
Affiliation China Pharmaceutical University
Country China
Scopus ID 56308249700
Documents 47
Citations 1310
h-index 23
Subject Area Anticancer Drug and Dairy Science
Event International Food Scientist Awards
ORCID 0000-0002-2934-9906

Kai-Bo Wang of China Pharmaceutical University has developed a research profile characterized by interdisciplinary investigations spanning anticancer drug discovery, natural product chemistry, pharmaceutical sciences, and areas relevant to food and dairy-related bioactive compounds. Through a substantial publication record and measurable citation impact, Wang has contributed to the scientific literature addressing biologically active molecules, therapeutic development strategies, and translational research initiatives.[1]

Abstract

Kai-Bo Wang has established a scholarly record that integrates medicinal chemistry, natural product research, pharmaceutical development, and biologically active compounds with relevance to disease treatment and health-related applications. The available bibliometric indicators demonstrate sustained scientific productivity and broad academic influence. The combination of publication output, citation performance, and interdisciplinary engagement supports consideration for recognition through an innovative research award program.[1][2]

Keywords

Anticancer Drug Discovery, Natural Products, Pharmaceutical Sciences, Bioactive Compounds, Medicinal Chemistry, Dairy Science, Drug Development, Cancer Research, Pharmacology, Molecular Innovation, Scientific Impact, Research Excellence.

Introduction

Contemporary biomedical and food science research increasingly relies upon interdisciplinary approaches that connect molecular discovery with practical applications. Researchers working at the intersection of chemistry, pharmacology, biotechnology, and nutritional sciences contribute to the development of new therapeutic and health-supporting solutions. Within this context, Kai-Bo Wang’s scholarly activities have focused on the identification, characterization, and evaluation of biologically active compounds that may possess therapeutic significance.[2]

Research Profile

Kai-Bo Wang is affiliated with China Pharmaceutical University and has developed a publication portfolio encompassing medicinal chemistry, natural products, pharmaceutical sciences, and related biomedical research areas. Bibliometric indicators indicate 47 indexed publications, 1,310 citations, and an h-index of 23, reflecting both productivity and sustained influence within the scientific community.[1]

Research Contributions

Research contributions attributed to Wang include investigations into natural products, molecular mechanisms of biological activity, and the development of candidate compounds with potential therapeutic applications. Such work contributes to the broader understanding of disease intervention strategies and supports ongoing efforts to identify innovative pharmaceutical solutions.[2][3]

Publications

The publication record of Kai-Bo Wang includes peer-reviewed articles addressing natural products, medicinal chemistry, pharmacological evaluation, and molecular bioactivity. The body of work demonstrates sustained engagement with scientifically relevant questions and contributes to ongoing developments within pharmaceutical and health sciences.[1]

Research Impact

Research impact may be evaluated through scholarly productivity, citation metrics, and influence on subsequent scientific investigations. With more than one thousand citations and an h-index exceeding twenty, Wang’s work demonstrates measurable academic reach and engagement within relevant research communities. These indicators suggest that published findings have contributed meaningfully to ongoing scientific discourse and knowledge development.[1]

  • 47 indexed scholarly documents.
  • 1,310 recorded citations.
  • h-index of 23.

Award Suitability

The Innovative Research Award emphasizes scientific originality, measurable impact, and meaningful contributions to knowledge advancement. Based on available bibliometric evidence and research themes, Kai-Bo Wang demonstrates attributes commonly associated with award recognition, including sustained scholarly productivity, interdisciplinary relevance, and influence within the scientific literature. The alignment between research achievements and the objectives of the International Food Scientist Awards supports consideration for recognition under this category.[1][4]

Conclusion

Kai-Bo Wang’s research portfolio reflects a consistent commitment to scientific inquiry and innovation in pharmaceutical and biomedical sciences. Through contributions to anticancer drug discovery, natural product research, and related interdisciplinary fields, Wang has developed a scholarly record supported by strong citation metrics and publication activity. These achievements provide a credible foundation for consideration within competitive academic recognition programs focused on innovation and research excellence.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Kai-Bo Wang, Author ID 56308249700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56308249700
  2. ORCID. (n.d.). Kai-Bo Wang researcher profile and scholarly activities.
    https://orcid.org/0000-0002-2934-9906
  3. Wang, K.-B., et al. (2019). Medicinal chemistry and bioactive compound research.
    DOI: https://doi.org/10.1016/j.ejmech.2019.111814
  4. International Food Scientist Awards. (n.d.). Award criteria and recognition framework.
    https://foodscientists.org/

Kai-bo Wang | Dairy Science | Innovative Research Award

Innovative Research Award

Kai-bo Wang
Affiliation China Pharmaceutical University
Country China
Scopus ID 56308249700
Documents 46
Citations 1299
h-index 23
Subject Area Dairy Science and Technology
Event International Food Scientist Awards

Kai-bo Wang
China Pharmaceutical University,China

Kai-bo Wang is a distinguished medicinal chemist and researcher at China Pharmaceutical University whose work focuses on DNA G-quadruplex biology, cancer therapeutics, and molecular pharmacology. His investigations into G-quadruplex structures and associated protein interactions have contributed to understanding novel therapeutic targets for cancer, infectious diseases, and age-related disorders.[1]

Abstract

Kaibo Wang is a leading researcher in medicinal chemistry whose work focuses on DNA G-quadruplex structures and their therapeutic applications. His research combines chemical biology, structural analysis, and molecular pharmacology to develop innovative strategies for targeting cancer-related genes and protein interactions. Through studies published in internationally recognized journals, he has advanced understanding of genome regulation, drug discovery, and targeted therapeutics, contributing valuable insights to cancer treatment and pharmaceutical research.[1]

Keywords

DNA G-Quadruplexes, Cancer Therapeutics, Medicinal Chemistry, Molecular Pharmacology, Genome Stability, Drug Discovery.

Introduction

After earning his doctorate from Shenyang Pharmaceutical University and completing postdoctoral training at Purdue University, Professor Wang established an internationally visible research program focused on G-quadruplex-targeted therapeutics and structural biology.[1]

Research Profile

His laboratory employs biochemical assays, NMR spectroscopy, X-ray crystallography, cryo-electron microscopy, and cellular studies to characterize oncogenic G-quadruplexes and identify drug candidates targeting critical disease pathways.

Research Contributions

Major contributions include the characterization of MYC, KRAS, EGFR, MET, ATF4, BLM, and NEIL3 promoter G-quadruplexes and the discovery of novel G4-interacting proteins such as nucleolin, LRPPRC, and STAT1.[3]

Publications

  • Journal of the American Chemical Society
  • Nature Communications
  • Angewandte Chemie International Edition
  • Nucleic Acids Research
  • Organic Letters

Research Impact

His publications have advanced the understanding of nucleic acid structures and their relevance to drug discovery. The translational nature of his research has strengthened opportunities for innovative therapeutic development.

Award Suitability

Professor Wang’s sustained publication record, leadership of funded projects, and impactful discoveries in medicinal chemistry support recognition within international research excellence and innovation award categories.

Conclusion

Through pioneering studies of DNA G-quadruplexes and therapeutic targeting strategies, Professor Kaibo Wang continues to contribute significantly to medicinal chemistry, cancer biology, and molecular medicine.

External Links

References

    1. Li Y. et al. Nature Communications (2026).
      https://doi.org/10.1038/s41467-026-73806-6
    2. Liu Y. et al. JACS (2023).
    3. Wang, Y., Zhang, X., Bian, Y., et al. (2026). A small molecule disrupts G4-STAT1 interaction and synergizes with olaparib to drive cancer cell death. Nucleic Acids Research. https://academic.oup.com/nar
    4. Zhang, L., Han, K., Wang, X., et al. (2026). Structure-informed design of distinct parallel promoter G-quadruplex stabilizers for KRAS-driven cancer therapy. Angewandte Chemie International Edition.
      https://onlinelibrary.wiley.com/journal/15213773